TW202317652A - A bio-inert material and its application for preventing biofouling from metal surface - Google Patents

A bio-inert material and its application for preventing biofouling from metal surface Download PDF

Info

Publication number
TW202317652A
TW202317652A TW110138636A TW110138636A TW202317652A TW 202317652 A TW202317652 A TW 202317652A TW 110138636 A TW110138636 A TW 110138636A TW 110138636 A TW110138636 A TW 110138636A TW 202317652 A TW202317652 A TW 202317652A
Authority
TW
Taiwan
Prior art keywords
copolymer
segment
sulfobetaine
vinyl
phosphoric acid
Prior art date
Application number
TW110138636A
Other languages
Chinese (zh)
Other versions
TWI800039B (en
Inventor
張雍
唐碩禧
陳登信
Original Assignee
中原大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中原大學 filed Critical 中原大學
Priority to TW110138636A priority Critical patent/TWI800039B/en
Application granted granted Critical
Publication of TWI800039B publication Critical patent/TWI800039B/en
Publication of TW202317652A publication Critical patent/TW202317652A/en

Links

Images

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The invention discloses a copolymer and its application for preventing biofouling from metal surface. The copolymer structure comprises a first segment and a second segment. The first segment comprises phosphonic acid groups, the second segment comprises pyridine sulfobetaine groups or pyridine carboxybetaine groups and the first segment bond with the second segment by covalent bonding to form the copolymer. Particularly, the phosphonic acid groups form coordinate covalent bonds with metal surface for anchoring function and the pyridine sulfobetaine groups or pyridine carboxybetaine groups prevent biofouling from the metal surface.

Description

一種共聚物及其應用在防止金屬表面沾黏生物分子 的方法 A kind of copolymer and its application in preventing metal surface from adhering biomolecules Methods

本發明揭示一種共聚物及其應用在防止金屬表面沾黏生物分子的方法。特別地,該共聚物之結構包含複數個磷酸基和複數個吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼。 The invention discloses a copolymer and a method for its application in preventing metal surfaces from adhering biomolecules. In particular, the structure of the copolymer contains a plurality of phosphoric acid groups and a plurality of pyridinesulfobetaine or pyridinecarboxybetaine.

市場上廣泛應用於治療心血管疾病的支架醫材包含裸金屬支架(Bare Metal Stent,BMS),其是單純的金屬支架,作用是撐開血管狹窄處,但有導致日後血管再狹窄化的缺點。另一種是塗藥型支架(Drug Eluting Stent,DES),其為在金屬支架表面塗佈一層含抑制細胞增生藥物的生物降解高分子,藉由緩慢的生物降解來逐漸釋放藥物,使得血管內皮細胞生長被抑制,雖然可避免血管再狹窄化,但卻使得凝血反應不斷發生,必須終生服用抗凝血藥物,且支架上的含藥數僅能維持5到10年,此為一大缺點,以上的支架材料都存在不同的缺點需要克服,以降低其在植入生物體後產生的副作用。 The stent medical materials widely used in the treatment of cardiovascular diseases in the market include Bare Metal Stent (BMS), which is a simple metal stent, and its function is to open the stenosis of the blood vessel, but it has the disadvantage of causing the restenosis of the blood vessel in the future. . The other is a drug-coated stent (Drug Eluting Stent, DES), which is coated with a layer of biodegradable polymers containing anti-cell proliferation drugs on the surface of the metal stent, and gradually releases drugs through slow biodegradation, making vascular endothelial cells The growth is inhibited. Although the restenosis of blood vessels can be avoided, the blood coagulation reaction continues to occur. Anticoagulant drugs must be taken for life, and the number of drugs on the stent can only be maintained for 5 to 10 years. This is a major disadvantage. The above All scaffold materials have different disadvantages that need to be overcome in order to reduce their side effects after being implanted in a living body.

根據前述,為了克服目前支架材料和植入生物體產生交互副作用的缺失,研究開發一結構穩定性佳又兼具生物惰性的材料實為現今生醫材料產業亟須投入研究開發的課題。 According to the above, in order to overcome the lack of side effects of current scaffold materials and implanted organisms, research and development of a material with good structural stability and biological inertness is an urgent research and development topic for the current biomedical material industry.

根據前述的發明背景和產業需求,本發明的技術手段和功效係揭示一具新穎結構的共聚物,該共聚物結構包含一能夠和基材起錨定/固定作用的磷酸基,和一耐裂解的具生物惰性的吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼官能基。特別地,本發明以上述之共聚物結構製造設計相關生物惰性材料並應用在防止金屬材料表面的生物分子沾黏。 According to the aforementioned background of the invention and industrial needs, the technical means and effects of the present invention disclose a copolymer with a novel structure, which contains a phosphoric acid group capable of anchoring/fixing the substrate, and a cracking-resistant Biologically inert pyridinesulfobetaine or pyridinecarboxybetaine functional groups. In particular, the present invention uses the above-mentioned copolymer structure to manufacture design-related biologically inert materials and apply them to prevent the adhesion of biomolecules on the surface of metal materials.

本發明第一目的在於提供一種新穎的共聚物,該共聚物之結構包含第一鏈段和第二鏈段,該第一鏈段包含複數個磷酸基,該第二鏈段包含複數個吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼,以及上述之第一鏈段和第二鏈段藉由共價鍵連結形成所述之共聚物。 The first object of the present invention is to provide a novel copolymer. The structure of the copolymer comprises a first segment and a second segment, the first segment comprises a plurality of phosphoric acid groups, and the second segment comprises a plurality of pyridinesulfone Acid-based betaine or pyridinecarboxylic acid-based betaine, and the above-mentioned first segment and second segment are connected by covalent bonds to form the copolymer.

具體地,該共聚物是使用乙烯基磷酸(Vinylphosphonic acid,VPA)與無酯類官能基的4-乙烯基吡啶磺酸基甜菜鹼(4-vinylpyridine propylsulfobetaine,4VPPS)以自由基聚合製成的乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物。 Specifically, the copolymer is ethylene produced by radical polymerization using vinylphosphonic acid (VPA) and 4-vinylpyridine sulfobetaine (4-vinylpyridine sulfobetaine, 4VPPS) without ester functional groups. Phosphate-4-vinylpyridinesulfonate betaine copolymer.

具體地,該乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物能和金屬材料的表面形成配位共價鍵結,藉此錨定在該金屬材料的表面。 Specifically, the vinyl phosphate-4-vinylpyridine sulfobetaine copolymer can form a coordination covalent bond with the surface of the metal material, thereby being anchored on the surface of the metal material.

具體地,上述之共聚物同時具有生物相容性、抗生物分子沾黏、易於錨定在基材表面和自身分子結構安定的技術效 果,能廣泛應用在製備生物惰性材料。 Specifically, the above-mentioned copolymer has the technical effects of biocompatibility, anti-biomolecular adhesion, easy anchoring on the surface of the substrate and stable molecular structure. The results can be widely used in the preparation of biologically inert materials.

本發明第二目的在於提供一種生物惰性材料,其包含一膜層和一基材,該膜層是由包含第一目的所述之共聚物的組成所構成,並以配位共價鍵結或化學接枝錨定在該基材的表面,藉此形成所述的生物惰性材料。 The second object of the present invention is to provide a biologically inert material, which includes a film layer and a substrate, the film layer is composed of the copolymer described in the first object, and is covalently bonded by coordination or The chemical graft is anchored to the surface of the substrate, thereby forming the bioinert material.

特別地,該膜層還包含一互穿聚合物網絡結構。 In particular, the film layer also includes an interpenetrating polymer network structure.

具體地,該共聚物之結構包含第一鏈段和第二鏈段,該第一鏈段包含複數個磷酸基,該第二鏈段包含複數個吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼,以及上述之第一鏈段和第二鏈段藉由共價鍵連結形成所述之共聚物。 Specifically, the structure of the copolymer includes a first segment and a second segment, the first segment includes a plurality of phosphoric acid groups, and the second segment includes a plurality of pyridine sulfobetaine or pyridinecarboxylate betaine The base, and the above-mentioned first chain segment and second chain segment are connected by covalent bonds to form the copolymer.

具體地,上述之生物惰性材料同時具有生物相容性、抗生物分子沾黏和材料結構安定的技術效果,能廣泛應用在生醫材料領域。 Specifically, the above-mentioned bioinert materials have the technical effects of biocompatibility, anti-biomolecular adhesion and stable material structure, and can be widely used in the field of biomedical materials.

本發明第三目的在於提供一種防止金屬表面沾黏生物分子的方法,其包含使本發明第一目的所述的共聚物配位共價鍵結在該金屬表面或以化學接枝形成互穿聚合物網絡結構,藉此防止該金屬表面沾黏生物分子。 The third object of the present invention is to provide a method for preventing the adhesion of biomolecules to the metal surface, which includes covalently bonding the copolymer described in the first object of the present invention on the metal surface or forming interpenetrating polymerization by chemical grafting The network structure of the object can prevent the metal surface from adhering to biomolecules.

具體地,該共聚物之結構包含第一鏈段和第二鏈段,該第一鏈段包含複數個磷酸基,該第二鏈段包含複數個吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼,以及上述之第一鏈段和第二鏈段藉由共價鍵連結形成所述之共聚物。 Specifically, the structure of the copolymer includes a first segment and a second segment, the first segment includes a plurality of phosphoric acid groups, and the second segment includes a plurality of pyridine sulfobetaine or pyridinecarboxylate betaine The base, and the above-mentioned first chain segment and second chain segment are connected by covalent bonds to form the copolymer.

具體地,該配位共價鍵結係由該磷酸基和該金屬表 面所含的鉻所形成。 Specifically, the coordinate covalent bond is formed by the phosphoric acid group and the metal surface Formed by the chromium contained in the surface.

綜上所述,本發明的技術特徵和效果包含:(1)提供一具有磷酸基和吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼結構的共聚物,其中該磷酸基和材料表面形成配位共價鍵結或互穿聚合物網絡結構,藉此錨定在該材料上以形成穩定的共聚物膜層結構;和上述之吡啶磺酸基甜菜鹼或或吡啶羧酸基甜菜鹼使該共聚物膜層達到抗生物分子沾黏等生物惰性的效果;(2)提供一新穎的生物惰性材料,特別是以金屬作為基材的生物惰性材料,該生物惰性材料包含以具有磷酸基和吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼結構的共聚物所構成的膜層,同時具有生物相容性、抗生物分子沾黏和材料結構安定的技術效果;(3)提供一種防止金屬材料表面沾黏生物分子的方法,藉由配位共價鍵結或以化學接枝形成互穿聚合物網絡結構使上述之具有磷酸基和吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼結構的共聚物錨定在該金屬材料的表面,藉此達到防止該金屬材料表面沾黏生物分子之目的,能廣泛應用於金屬製醫材領域。 In summary, the technical features and effects of the present invention include: (1) provide a copolymer with phosphoric acid group and pyridine sulfonate betaine or pyridine carboxylate betaine structure, wherein the phosphoric acid group forms a complex with the surface of the material Covalent bonding or interpenetrating polymer network structure, thereby anchored on the material to form a stable copolymer film structure; The copolymer film layer achieves the biological inert effects such as anti-biomolecular adhesion; (2) provide a novel biological inert material, especially a biological inert material with metal as the base material, the biological inert material comprises a phosphate group and a pyridine The film layer composed of a copolymer of sulfobetaine or pyridinecarboxylate betaine structure has the technical effects of biocompatibility, anti-biomolecule adhesion and stable material structure; The method of sticking biomolecules on the surface, through coordination covalent bonding or chemical grafting to form an interpenetrating polymer network structure to make the above-mentioned ones with the structure of phosphate group and pyridine sulfonate betaine or pyridine carboxylate betaine The copolymer is anchored on the surface of the metal material, thereby achieving the purpose of preventing the surface of the metal material from adhering to biomolecules, and can be widely used in the field of metal medical materials.

〔圖1〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)的FTIR圖譜;對照組是Poly(VPA-r-SBMA)共聚物。 [Figure 1] is the FTIR spectrum of the vinyl phosphate-4-vinylpyridinesulfonate betaine copolymer poly(VPA- r -4VPPS) of the present invention; the control group is Poly(VPA- r -SBMA) copolymer.

〔圖2〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚 物poly(VPA-r-4VPPS)的水接觸角長條圖。 [Fig. 2] is a bar graph of the water contact angle of the vinylphosphoric acid-4-vinylpyridinesulfonate betaine copolymer poly(VPA- r -4VPPS) of the present invention.

〔圖3〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)的水合含量長條圖。 [Fig. 3] is a bar graph of the hydration content of the vinylphosphoric acid-4-vinylpyridinesulfonate betaine copolymer poly(VPA- r -4VPPS) of the present invention.

〔圖4〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)的顯微鏡影像圖和人類纖維母細胞相對貼附量長條圖;對照組是SBMA水膠。 〔Fig. 4〕is the micrograph of the vinyl phosphate-4-vinylpyridine sulfonate betaine copolymer poly(VPA- r -4VPPS) of the present invention and the bar graph of the relative attachment amount of human fibroblasts; the control group It is SBMA water glue.

〔圖5〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)的凝血時間長條圖。 [Fig. 5] is a bar chart of the coagulation time of the vinylphosphoric acid-4-vinylpyridinesulfonate betaine copolymer poly(VPA- r -4VPPS) of the present invention.

〔圖6〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)的溶血測試百分比長條圖。 [Fig. 6] is a bar graph of the hemolysis test percentage of vinylphosphoric acid-4-vinylpyridinesulfonate betaine copolymer poly(VPA- r -4VPPS) of the present invention.

〔圖7〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)的細胞毒性分析顯微鏡影像圖和分級。 [Fig. 7] is the microscope image and grading of cytotoxicity analysis of vinylphosphoric acid-4-vinylpyridinesulfonate betaine copolymer poly(VPA- r -4VPPS) of the present invention.

〔圖8〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)的熱重損失分析(TGA)圖譜;對照組是Poly(VPA-r-SBMA)共聚物。 [Fig. 8] is the thermogravimetric analysis (TGA) spectrum of vinyl phosphate-4-vinylpyridinesulfonic acid betaine copolymer poly(VPA- r -4VPPS) of the present invention; the control group is Poly(VPA- r- SBMA) copolymer.

〔圖9〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物poly(VPA-r-4VPPS)在滅菌前後的人類全血顯微鏡影像圖和人類全血相對貼附量長條圖;對照組是SBMA水膠。 [Fig. 9] Microscope images of human whole blood before and after sterilization of vinyl phosphate-4-vinylpyridinesulfonic acid betaine copolymer poly(VPA- r -4VPPS) of the present invention and the relative attachment amount of human whole blood Bar graph; control group is SBMA hydrogel.

〔圖10〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物PPA70及其共聚物互穿網絡(PPA70-PVA)膜層的人類纖維母細胞相對貼附量長條圖;對照組是SBMA水膠。 [Fig. 10] is the bar chart of the relative amount of human fibroblasts attached to the film layer of vinylphosphoric acid-4-vinylpyridinesulfonic acid betaine copolymer PPA70 and its copolymer interpenetrating network (PPA70-PVA) of the present invention ; The control group was SBMA hydrogel.

〔圖11〕係本發明乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚 物PPA70及其共聚物互穿網絡(PPA70-PVA)膜層的綠色螢光蛋白大腸桿菌相對貼附量長條圖;對照組是SBMA水膠。 〔Figure 11〕It is vinyl phosphoric acid-4-vinylpyridinesulfonic acid betaine copolymerization of the present invention The bar chart of the relative attachment amount of green fluorescent protein Escherichia coli on the film layer of PPA70 and its copolymer interpenetrating network (PPA70-PVA); the control group is SBMA water glue.

以上雖以特定範例說明本發明,但並不因此限定本發明之範圍,只要不脫離本發明之要旨,熟悉本技藝者瞭解在不脫離本發明的意圖及範圍下可進行各種變形或變更。此外,摘要部分和標題僅是用來輔助專利文件搜尋之用,並非用來限制本發明之權利範圍。 Although the present invention has been described above with specific examples, the scope of the present invention is not limited thereto. Those skilled in the art understand that various modifications or changes can be made without departing from the intent and scope of the present invention. In addition, the abstract and the title are only used to assist the search of patent documents, and are not used to limit the scope of rights of the present invention.

依據前述發明內容,本發明第一實施例在於提供一種共聚物,其結構包含第一鏈段和第二鏈段,該第一鏈段包含複數個磷酸基,該第二鏈段包含複數個吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼,以及上述之第一鏈段和第二鏈段藉由共價鍵連結形成所述之共聚物。 According to the aforementioned content of the invention, the first embodiment of the present invention is to provide a copolymer whose structure includes a first chain segment and a second chain segment, the first chain segment contains a plurality of phosphoric acid groups, and the second chain segment contains a plurality of pyridine The sulfobetaine or pyridinecarboxybetaine, and the above-mentioned first chain segment and second chain segment are connected by covalent bonds to form the copolymer.

於一實施例,該共聚物具有如下結構通式,其中m是5~500的整數,n是5~500的整數;R是帶有羧酸根(Carboxylic acid)或磺酸根(sulfonic acid)的官能基;k是1~3重複的碳鏈。 In one embodiment, the copolymer has the following general structural formula, wherein m is an integer of 5-500, n is an integer of 5-500; R is a functional group with carboxylic acid or sulfonic acid base; k is a carbon chain with 1~3 repetitions.

式(1)

Figure 110138636-A0101-12-0007-3
Formula 1)
Figure 110138636-A0101-12-0007-3

於一具體實施例,該共聚物是乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物,其化學結構如式(2)所示,其中m是20~400的整數,n是30~300的整數。 In a specific embodiment, the copolymer is vinylphosphoric acid-4-vinylpyridinesulfonic acid betaine copolymer, its chemical structure is shown in formula (2), wherein m is an integer of 20 to 400, and n is 30 Integer of ~300.

式(2)

Figure 110138636-A0101-12-0007-4
Formula (2)
Figure 110138636-A0101-12-0007-4

於一具體實施例,該乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物的重量平均分子量是小於120kDa,較佳的,其範圍是50~120kDa。 In a specific embodiment, the weight average molecular weight of the vinyl phosphate-4-vinylpyridine sulfobetaine copolymer is less than 120 kDa, preferably, the range is 50-120 kDa.

於一具體實施例,該乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物是由乙烯基磷酸和4-乙烯基吡啶磺酸基甜菜鹼進行自由基聚合反應所製成,該乙烯基磷酸和4-乙烯基吡啶磺酸基甜菜鹼的反應莫耳比例範圍是約9:1到1:9。較佳的,是7:3到3:7。 In a specific embodiment, the vinyl phosphate-4-vinylpyridine sulfobetaine copolymer is prepared by free radical polymerization of vinyl phosphate and 4-vinylpyridine sulfobetaine, the vinyl The reaction molar ratio of phosphonyl phosphoric acid and 4-vinylpyridine sulfobetaine ranges from about 9:1 to 1:9. Preferably, it is 7:3 to 3:7.

本發明第二實施例在於提供一種生物惰性材料,其包含一膜層和一基材,該膜層包含如本發明第一實施例所提供之共聚物,和該膜層藉由配位共價鍵結或化學接枝錨定在該基材的表面,藉此形成所述的生物惰性材料。 The second embodiment of the present invention is to provide a biologically inert material, which includes a film layer and a substrate, the film layer includes the copolymer as provided in the first embodiment of the present invention, and the film layer is covalently Bonding or chemical grafting is anchored to the surface of the substrate, thereby forming the bioinert material.

於一具體實施例,該共聚物是乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物,其重量平均分子量是約50~120kDa。 In a specific embodiment, the copolymer is vinyl phosphate-4-vinylpyridine sulfobetaine copolymer, and its weight average molecular weight is about 50-120 kDa.

於一具體實施例,該乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物是由乙烯基磷酸和4-乙烯基吡啶磺酸基甜菜鹼進行自由基聚合反應所製成,該乙烯基磷酸和4-乙烯基吡啶磺酸基甜菜鹼的反應莫耳比例範圍是約7:3到3:7。 In a specific embodiment, the vinyl phosphate-4-vinylpyridine sulfobetaine copolymer is prepared by free radical polymerization of vinyl phosphate and 4-vinylpyridine sulfobetaine, the vinyl The reaction molar ratio of phosphonyl phosphoric acid and 4-vinylpyridine sulfobetaine ranges from about 7:3 to 3:7.

於一具體實施例,該膜層的水接觸角約是小於60度,較佳的,是30~50度。 In a specific embodiment, the water contact angle of the film layer is about less than 60 degrees, preferably 30-50 degrees.

於另一具體實施例,該膜層還包含一如式(3)所示的聚乙烯醇和乙烯基磷酸所形成的互穿聚合物網絡結構,其中X是5~500的整數,較佳的,是20~400的整數,Y是5~7000的整數,較佳的,Y是30~1500的整數。 In another specific embodiment, the film layer also includes an interpenetrating polymer network structure formed by polyvinyl alcohol and vinyl phosphoric acid as shown in formula (3), wherein X is an integer of 5-500, preferably, is an integer of 20-400, Y is an integer of 5-7000, preferably, Y is an integer of 30-1500.

式(3)

Figure 110138636-A0101-12-0008-5
Formula (3)
Figure 110138636-A0101-12-0008-5

於另一具體實施例,該基材包含不鏽鋼、鈦合金、玻璃、矽晶圓、陶瓷、聚對苯二甲酸乙二酯、聚丙烯、聚二甲基矽氧烷、聚四氟乙烯或聚偏二氟乙烯。 In another specific embodiment, the substrate comprises stainless steel, titanium alloy, glass, silicon wafer, ceramic, polyethylene terephthalate, polypropylene, polydimethylsiloxane, polytetrafluoroethylene or poly Vinylidene fluoride.

於另一具體實施例,所述之生物惰性材料,係應用於製備心導管、血管支架、內視鏡或手術器械。 In another specific embodiment, the biologically inert material is applied to the preparation of cardiac catheters, vascular stents, endoscopes or surgical instruments.

本發明第三實施例在於提供一種防止金屬表面沾黏生物分子的方法,包含使本發明第一實施例所述的共聚物配位共價鍵結在該金屬表面或以化學接枝形成互穿聚合物網絡結構,藉此防止該金屬表面沾黏生物分子,該配位共價鍵結係由磷酸基和該金屬表面所含的鉻所形成。 The third embodiment of the present invention is to provide a method for preventing the metal surface from adhering to biomolecules, including covalently bonding the copolymer described in the first embodiment of the present invention on the metal surface or forming interpenetration by chemical grafting The polymer network structure prevents the metal surface from adhering to biomolecules, and the coordination covalent bond is formed by phosphoric acid groups and chromium contained in the metal surface.

特別地,上述實施例提及之技術特徵和功效能夠解決裸金屬支架與塗藥型支架現今存在的問題。利用本發明之共聚物材料在金屬支架創造一層抗生物分子沾黏的膜層或進行其表面改質,使其具有生物相容性,能夠抵抗細胞的黏附,但又不會抑制細胞生長;另一方面本發明的共聚物和其構成的膜層還能抑制血液細胞的貼附,避免凝血、溶血等反應發生,進一步降低抗凝血藥物的服用。據此,本發明之共聚物、生物惰性材料和應用方法在生醫產業,尤其是侵入式醫材產業著實具有習知技術無法預期的功效。 In particular, the technical features and functions mentioned in the above embodiments can solve the current problems of bare metal stents and drug-coated stents. Using the copolymer material of the present invention to create a layer of anti-biomolecule adhesion film layer on the metal stent or modify its surface to make it biocompatible and able to resist cell adhesion without inhibiting cell growth; On the one hand, the copolymer of the present invention and the film layer formed by it can also inhibit the attachment of blood cells, avoid reactions such as coagulation and hemolysis, and further reduce the taking of anticoagulant drugs. Accordingly, the copolymer, biologically inert material and application method of the present invention have unexpected effects in the biomedical industry, especially in the invasive medical material industry.

以下範例和實驗例係依據上述之發明內容和實施例所述之內容所進行的實驗,並據此做為本發明的效果驗證和說明。 The following examples and experimental examples are experiments carried out according to the content described in the above-mentioned content of the invention and the embodiments, and are used as effect verification and description of the present invention accordingly.

範例一:乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共Example 1: Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine 聚物(poly(VPA-r-4VPPS))合成Polymer (poly(VPA- r -4VPPS)) synthesis

利用自由基聚合(Free Radical Polymerization)方式合成poly(VPA-r-4VPPS),並控制乙烯基磷酸(VPA):4-乙烯基吡啶磺酸基甜菜鹼(4VPPS)之莫耳比例,如表1所示,並控制理論分子量約在50kDa,實際分子量是由凝膠滲透層析儀(Gel Permeation Chromatography,GPC)所測定。共聚高分子合成的反應如段落[0036]所示,將VPA與4VPPS單體放入聚丙烯(PP)反應瓶中,以1M NaCl水溶液作為溶劑溶解單體,加入過硫酸銨(Ammonium persulphate,APS)作為起始劑並溶解後,以氬氣通氣15分鐘,去除溶液中的氧氣與水氣,隨後密封瓶口,並置於70℃油浴鍋中攪拌反應48小時。反應完成的產物浸泡於冰浴中終止反應,並以丙酮為非溶劑析出高分子,將析出完之共聚高分子放入真空乾燥設備移除殘留的溶劑,即完成共聚高分子的合成。本發明的對照組是以乙烯基磷酸(VPA)和磺酸基甜菜鹼甲基丙烯酸酯單體(SBMA)合成之Poly(VPA-r-SBMA)共聚物。 Synthesize poly(VPA- r -4VPPS) by free radical polymerization (Free Radical Polymerization), and control the molar ratio of vinylphosphoric acid (VPA): 4-vinylpyridinesulfobetaine (4VPPS), as shown in Table 1 As shown, and the theoretical molecular weight is controlled at about 50kDa, the actual molecular weight is determined by gel permeation chromatography (Gel Permeation Chromatography, GPC). The reaction of copolymerization macromolecule synthesis is as shown in paragraph [0036], VPA and 4VPPS monomer are put into polypropylene (PP) reaction bottle, with 1M NaCl aqueous solution as solvent dissolution monomer, add ammonium persulfate (Ammonium persulphate, APS ) as the starting agent and dissolved, ventilate with argon for 15 minutes to remove oxygen and moisture in the solution, then seal the bottle mouth, and place it in an oil bath at 70° C. to stir for 48 hours. The finished product is soaked in an ice bath to terminate the reaction, and acetone is used as a non-solvent to precipitate the polymer, and the precipitated copolymer polymer is placed in a vacuum drying device to remove the residual solvent, and the synthesis of the copolymer polymer is completed. The control group of the present invention is Poly(VPA- r- SBMA) copolymer synthesized from vinyl phosphoric acid (VPA) and sulfobetaine methacrylate monomer (SBMA).

表1

Figure 110138636-A0101-12-0010-6
Table 1
Figure 110138636-A0101-12-0010-6

Figure 110138636-A0101-12-0011-7
Figure 110138636-A0101-12-0011-7

反應方程式 Reaction equation

Figure 110138636-A0101-12-0011-8
Figure 110138636-A0101-12-0011-8

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(poly(VPA-r-4VPPS))FT-IR分析FT-IR Analysis of Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine Copolymer (poly(VPA- r -4VPPS))

應用FT-IR檢測共聚物結構中的鍵結與官能基,在Poly(VPA-r-4VPPS)共聚物中,能檢測到特徵官能基,分析圖譜如圖1所示。吡啶(Pyridine)的波數為1571~1423cm-1;Poly(VPA-r-SBMA)共聚物檢測到波數1725cm-1 C=O特徵官能基;此外,在各比例的共聚物中,都檢測到波數為1641~1643cm-1的C-N+鍵結、1201~1043cm-1的SO3鍵結與983~925cm-1的P-O鍵結,據此證明範例一使用磷酸基的單體與雙離子單體的自由基聚合方法成功製成本發明的Poly(VPA-r-4VPPS)共聚物。 FT-IR was used to detect the bonds and functional groups in the copolymer structure. In the Poly(VPA- r -4VPPS) copolymer, the characteristic functional groups could be detected. The analysis spectrum is shown in Figure 1. The wavenumber of Pyridine is 1571~1423cm -1 ; the wavenumber of Poly(VPA- r -SBMA) copolymer is 1725cm -1 C=O characteristic functional group; To the CN + bond with a wave number of 1641~1643cm -1 , the SO 3 bond with 1201~1043cm -1 and the PO bond with 983~925cm -1 , it is proved that the example 1 uses a phosphoric acid group monomer and double ion The Poly(VPA- r -4VPPS) copolymer of the present invention is successfully prepared by the free radical polymerization method of the monomer.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(poly(VPA-r-4VPPS))改質材料表面的水接觸角分析Analysis of Water Contact Angle of Surface Modified by Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine Copolymer (poly(VPA- r -4VPPS))

本實驗以不鏽鋼作為要表面改質的材料,以賦予其 具有生物惰性,改質前後的不鏽鋼表面進行水接觸角分析,藉此證明本發明共聚物在材料表面能形成穩定結構的技術功效。具體地,以1M NaCl為溶劑,將Poly(VPA-r-4VPPS)共聚高分子以40mg/mL的比例配置成高分子溶液,在24孔多孔盤中,每一格置入1片不鏽鋼錠,並加入1mL的高分子溶液,將多孔盤以鐵氟龍止瀉帶包覆後,置入60℃烘箱反應48小時,當反應完成後,以1M NaCl溶液反覆清洗,將未接枝上的高分子清除,再以去離子水清洗,將殘留的NaCl洗去,之後將水分吸乾,即完成不鏽鋼的表面改質。本實驗中的水接觸角檢測方法為將4μL的去離子水水滴於室溫環境下,滴至不鏽鋼樣品的表面,並等待其平衡3分鐘後,量測其水接觸角,實驗結果如圖2所示。其中Poly(VPA-r-4VPPS)共聚物改質的不鏽鋼相比未改質的不鏽鋼,接觸角大幅降低約60°,較佳的條件為PPA70的36.8°,證實使疏水的不鏽鋼表面已經改質轉變成親水表面。但是PPA100為單純的VPA均聚高分子,兩個-OH官能基會與不鏽鋼表面的氧化鉻(Cr2O3)鍵結,結構上只剩一個親水的P=O官能基,因此水接觸角下降的趨勢明顯比本發明的共聚物要小。P4VPPS則為4VPPS的均聚物,在缺乏磷酸基單體(VPA)的條件下,無法與不鏽鋼表面形成穩定的鍵結,在改質完後的清洗純化程序被沖洗,導致水接觸角無法有效降低,所以沒有磷酸基的共聚物是無法和材料表面形成的穩定結構,達到材料表面改質後具有良好親水性之目的。 In this experiment, stainless steel was used as the material to be surface modified to endow it with biological inertness. Water contact angle analysis was performed on the stainless steel surface before and after modification, thereby proving the technical efficacy of the copolymer of the present invention that can form a stable structure on the surface of the material. Specifically, using 1M NaCl as the solvent, the Poly(VPA- r -4VPPS) copolymerized polymer was configured into a polymer solution at a ratio of 40 mg/mL, and a stainless steel ingot was placed in each grid in a 24-well porous plate. And add 1mL of polymer solution, cover the porous plate with Teflon antidiarrheal tape, put it in a 60°C oven to react for 48 hours, when the reaction is completed, wash it repeatedly with 1M NaCl solution, and remove the ungrafted high Molecules are removed, and then cleaned with deionized water to wash away the residual NaCl, and then the water is blotted dry to complete the surface modification of stainless steel. The water contact angle detection method in this experiment is to drop 4 μL of deionized water onto the surface of the stainless steel sample at room temperature, wait for it to balance for 3 minutes, and then measure its water contact angle. The experimental results are shown in Figure 2 shown. Among them, the contact angle of the stainless steel modified by Poly(VPA- r -4VPPS) copolymer is significantly reduced by about 60° compared with the unmodified stainless steel, and the better condition is 36.8° of PPA70, which proves that the surface of the hydrophobic stainless steel has been modified. into a hydrophilic surface. However, PPA100 is a pure VPA homopolymer, and the two -OH functional groups will bond with the chromium oxide (Cr 2 O 3 ) on the stainless steel surface, leaving only one hydrophilic P=O functional group in the structure, so the water contact angle The downward trend is significantly smaller than for the copolymers of the present invention. P4VPPS is a homopolymer of 4VPPS. In the absence of phosphate-based monomer (VPA), it cannot form a stable bond with the stainless steel surface. After the modification, the cleaning and purification process is washed, resulting in an ineffective water contact angle. Therefore, the copolymer without phosphoric acid group cannot form a stable structure with the surface of the material, so as to achieve the purpose of having good hydrophilicity after the surface of the material is modified.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(poly(VPA-r-4VPPS))改質材料表面的水合能力分析Analysis of Hydration Ability of the Surface of Modified Materials with Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine Copolymer (poly(VPA- r -4VPPS))

水合能力是用來評估材料表面的生物惰性的一項指標,水合能力越高表示材料表面的抗生物分子沾黏的效果越好,能在生物環境中捕捉更多水分子,在其表面形成水合層,有效降低生物分子與材料表面之間的分子間作用力,進而增加材料表面的抗生物分子沾黏特性。本發明具體之實驗結果如圖3所示,在經過poly(VPA-r-4VPPS)改質的不鏽鋼表面,相對於未改質的表面,顯著提升該不鏽鋼表面的水合能力,最佳的條件為PPA70,相對於未改質的不鏽鋼提升高達約200%的水合能力,具體的,由PPA70所改質的不鏽鋼,水合能力平均為0.097mg/cm2Hydration capacity is an indicator used to evaluate the biological inertia of the material surface. The higher the hydration capacity, the better the anti-biomolecule adhesion effect on the surface of the material, which can capture more water molecules in the biological environment and form hydration on its surface. The layer can effectively reduce the intermolecular force between biomolecules and the material surface, thereby increasing the anti-biomolecular adhesion properties of the material surface. The specific experimental results of the present invention are shown in Figure 3. Compared with the unmodified surface, the surface of stainless steel modified by poly(VPA- r -4VPPS) significantly improves the hydration capacity of the stainless steel surface. The optimal condition is Compared with unmodified stainless steel, PPA70 has a hydration capacity of about 200%. Specifically, the average hydration capacity of stainless steel modified by PPA70 is 0.097 mg/cm 2 .

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(poly(VPA-r-4VPPS))生物惰性效能分析之一One of the Bioinert Efficacy Analysis of Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine Copolymer (poly(VPA- r -4VPPS))

本實驗所使用的細胞為人類纖維母細胞(HT1080)。將培養至9成滿細胞的75T Flask以1mL的胰蛋白酶(Trypsin-EDTA)與細胞外基質反應6分鐘使細胞懸浮,並加入9mL的細胞培養液終止胰蛋白酶的反應,將細胞懸浮液在15mL離心管中以290rcf離心5分鐘後,將上清液移除後,再以10mL的細胞培養液將細胞沖散。以細胞計數盤在顯微鏡底下計算細胞數量,並以培養液將細胞數量稀釋至50,000cells/mL。將樣品放置於24well plate中以PBS膨潤12小時,並以UV燈殺菌30分鐘後放入生物安全櫃中,移除well plate中的 PBS,並以1mL的PBS清洗樣品2次後,下入1mL稀釋完的細胞液,並放入恆濕恆溫培養箱中以37℃,5% CO2培養24小時。將培養後的樣品以PBS清洗3次,加入戊二醛作為細胞固定劑,待反應1小時後,以PBS清洗1次,並以螢光顯微鏡觀測細胞在材料表面的貼附量,使用電腦軟體做定量的分析。實驗結果如圖4所示,係為HT1080貼附在材料表面的分析圖以及螢光顯微鏡下的畫面,顯示PPA70為其中之一較佳的抗細胞貼附條件,在經過PPA70所改質的不鏽鋼表面,相較於未改質不鏽鋼的細胞貼附量,平均每平方公分大幅降低15,000顆細胞數,形成有效的抗細胞沾黏表面。 The cells used in this experiment were human fibroblasts (HT1080). The 75T Flask cultured to 90% full cells was reacted with 1mL trypsin-EDTA with the extracellular matrix for 6 minutes to suspend the cells, and 9mL of cell culture medium was added to stop the trypsin reaction, and the cell suspension was dissolved in 15mL After the centrifuge tube was centrifuged at 290 rcf for 5 minutes, the supernatant was removed, and the cells were washed away with 10 mL of cell culture medium. Count the number of cells under a microscope with a cell counting disc, and dilute the number of cells to 50,000 cells/mL with culture medium. Place the sample in a 24well plate and inflate it with PBS for 12 hours, sterilize it with UV light for 30 minutes, put it in a biological safety cabinet, remove the PBS in the well plate, wash the sample twice with 1mL of PBS, and pour 1mL The diluted cell solution was placed in a constant humidity and constant temperature incubator at 37°C, 5% CO 2 for 24 hours. The cultured samples were washed 3 times with PBS, and glutaraldehyde was added as a cell fixative. After reacting for 1 hour, they were washed once with PBS, and the amount of cells attached to the surface of the material was observed with a fluorescent microscope. Using computer software Do quantitative analysis. The experimental results are shown in Figure 4, which is the analysis chart of HT1080 attached to the surface of the material and the picture under the fluorescent microscope, showing that PPA70 is one of the better anti-cell attachment conditions, and the stainless steel modified by PPA70 On the surface, compared with the cell attachment amount of unmodified stainless steel, the average number of cells per square centimeter is greatly reduced by 15,000, forming an effective anti-cell adhesion surface.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(poly(VPA-r-4VPPS))生物惰性效能分析之二Bio-inert performance analysis of vinyl phosphate-4-vinylpyridine sulfonate betaine copolymer (poly(VPA- r -4VPPS))

本凝血分析實驗係將不鏽鋼錠浸泡在1mL乏血小板血漿(Platelet poor plasma,PPP)中,並於37℃水浴平衡1小時,將平衡完的PPP吸取至樣品管中,並使用凝血時間分析儀(CA-600 series),設定檢測項目為凝血酶原時間(Prothrombin Time,PT)及活化部分凝血活酶時間(Activated Partial Thromboplastin Time,APTT),儀器將會自動注入檢測試劑與PPP混合,並以波長660nm,進行光散射強度的檢測。比較浸泡完樣品的PPP與單純PPP正常值反應時間的差異。依據ISO 10993的生物相容性規範,接觸血液的醫療器材必須進行凝血分析。本研究檢測了不鏽鋼的凝血酶原時間(Prothrombin Time,PT)與活 化部分凝血活酶時間(Activated Partial Thromb oplastin Time,APTT),分別是檢測外源性凝血與內源性凝血,PT的正常值為12~16秒,APTT的正常值為24~36秒;將浸泡不鏽鋼的PPP與單純的PPP所測出來的值做比較,由圖5所示,經由共聚高分子改質的不鏽鋼表面並不會造成凝血的反應。 In this coagulation analysis experiment, stainless steel ingots were soaked in 1 mL of platelet poor plasma (PPP), and equilibrated in a water bath at 37°C for 1 hour, and the equilibrated PPP was drawn into the sample tube, and the coagulation time analyzer ( CA-600 series), set the detection items as prothrombin time (Prothrombin Time, PT) and activated partial thromboplastin time (Activated Partial Thromboplastin Time, APTT), the instrument will automatically inject the detection reagent mixed with PPP, and the wavelength 660nm for detection of light scattering intensity. The difference in the normal value reaction time between the PPP of the soaked sample and the normal value of PPP was compared. According to the biocompatibility specification of ISO 10993, coagulation analysis must be carried out for medical devices that come into contact with blood. In this study, the relationship between prothrombin time (PT) and activity of stainless steel was detected. The activated partial thromboplastin time (Activated Partial Thromb oplastin Time, APTT) is used to detect extrinsic coagulation and intrinsic coagulation respectively. The normal value of PT is 12-16 seconds, and the normal value of APTT is 24-36 seconds; Comparing the measured values of PPP immersed in stainless steel and pure PPP, as shown in Figure 5, the surface of stainless steel modified by copolymerized polymer does not cause blood coagulation reaction.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(poly(VPA-r-4VPPS))生物惰性效能分析之三Bioinert performance analysis of vinyl phosphate-4-vinylpyridine sulfonate betaine copolymer (poly(VPA- r -4VPPS))

將全血先以PBS稀釋成總體積為800μL不同濃度的稀釋液,並取200μL加入3.33mL的PBS,取其中200μL檢測波長542nm的吸光值,並找出OD542=0.7~0.8的濃度值。使用適當的濃度,配置全血稀釋液,將稀釋液取200μL加入內含3.33mL PBS與不鏽鋼樣品的15mL離心管中,並準備PBS與DI water作為凝血的控制條件。將離心管置於37℃水浴槽中恆溫1小時,恆溫過後的離心管以180rcf的轉速離心10分鐘,取離心完的上清液200μL去檢測波長542nm的吸光值,以PBS與DI water所檢測的OD值設定為0%與100%,當溶血程度低於5%時,視為樣品不會造成溶血,利用下列公式計算不同條件的溶血程度。 The whole blood was first diluted with PBS to a total volume of 800 μL of diluents of different concentrations, and 200 μL was added to 3.33 mL of PBS, and 200 μL was taken to detect the absorbance at a wavelength of 542 nm, and the concentration value of OD 542 =0.7~0.8 was found. Use an appropriate concentration to prepare whole blood dilution, add 200 μL of the dilution to a 15mL centrifuge tube containing 3.33mL PBS and stainless steel samples, and prepare PBS and DI water as control conditions for coagulation. Place the centrifuge tube in a 37°C water bath to keep the temperature constant for 1 hour. After the constant temperature, the centrifuge tube is centrifuged at a speed of 180 rcf for 10 minutes. Take 200 μL of the centrifuged supernatant to detect the absorbance at a wavelength of 542 nm, which is detected by PBS and DI water The OD value is set as 0% and 100%. When the degree of hemolysis is lower than 5%, it is considered that the sample will not cause hemolysis. The following formula is used to calculate the degree of hemolysis under different conditions.

Hemolysis=(ODSUS-ODPBS)/(ODDI-ODPBS)×100% Hemolysis=(OD SUS -OD PBS )/(OD DI -OD PBS )×100%

ODSUS:各條件之不鏽鋼經溶血實驗所測得之OD 值;ODPBS:負控制組PBS所測得之OD值;ODDI正控制組DIWater所測得之OD值。 OD SUS : the OD value of the stainless steel in each condition measured by the hemolysis test; OD PBS : the OD value measured by the PBS of the negative control group; OD DI : the OD value measured by the DIWater of the positive control group.

在上述溶血分析中,以PBS為不會溶血的負控制組,去離子水為會造成溶血的正控制組,將本發明共聚物材料浸泡在血液中,並使用UV-VIS觀測血球是否因該共聚物材料造成溶血導致血紅素溶解至稀釋血液的PBS中,並以公式計算各條件的不鏽鋼所造成的溶血程度。由圖7所示,以本發明共聚物改質的不鏽鋼不會造成溶血反應。 In the above-mentioned hemolysis analysis, take PBS as the negative control group that will not hemolysis, and deionized water as the positive control group that will cause hemolysis, soak the copolymer material of the present invention in the blood, and use UV-VIS to observe whether the blood cells are affected by the hemolysis. The hemolysis caused by the copolymer material leads to the dissolution of hemoglobin into the PBS that dilutes the blood, and the degree of hemolysis caused by the stainless steel of each condition is calculated by the formula. As shown in Figure 7, the stainless steel modified with the copolymer of the present invention does not cause hemolysis.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(poly(VPA-r-4VPPS))生物惰性效能分析之四Bioinert performance analysis of vinyl phosphate-4-vinylpyridine sulfonate betaine copolymer (poly(VPA- r -4VPPS))

本發明提供之共聚物之細胞毒性是依據法規ISO 10993-5規定的標準流程進行檢測,使用的細胞為小鼠纖維母細胞(L929)進行實驗,總共分為3天的時長進行,並分為顯微鏡定性觀測與XTT試劑定量檢測。第一天分為細胞培養與樣品毒性萃取。細胞培養:將培養在細胞培養箱中的L929細胞取出,以PBS沖洗2次;加入1mL的胰蛋白酶(Trypsin-EDTA)反應6分鐘使細胞於Flask上脫附;使用顯微鏡觀測細胞已完全脫附,加入9mL的細胞培養液終止胰蛋白酶的反應;將脫附的細胞移至15mL的離心管,以290rcf的轉速離心5分鐘;將離心完的上清液移除,再以10mL的細胞培養液沖散離心管底部的細胞;將細胞使用細胞計數盤計算細胞數,並以細胞培養液稀釋細胞;欲用顯微鏡觀測之樣品的細胞濃度為150,000 cells/mL,於12孔多孔盤各加入1mL的細胞稀釋液至並放入細胞培養箱培養24小時;欲以XTT試劑檢測之細胞濃度為100,000cells/mL,並於96孔多孔盤各加入0.1mL至並放入細胞培養箱培養24小時。樣品毒性萃取:將樣品以UV燈將樣品殺菌30分鐘,並將L929細胞培養液將不鏽鋼以6cm2/mL的比例進行萃取,同時,以0.2g/mL的比例進行HDPE的萃取,作為細胞毒性的正控制組,並以0.1g/mL的比例進行ZDEC的萃取,作為細胞毒性的負控制組,以37℃、150rpm的條件進行萃取。第二天將第1天的將培養細胞的培養液,置換成萃取樣品的萃取液,12孔盤各加入1mL、96孔盤各加入0.1mL,並繼續放入細胞培養箱培養24小時。第三天分為定性及定量,定性:將12孔盤的細胞以細胞培養液清洗2次,並在顯微鏡下觀測細胞生長的情況。定量:將XTT試劑與XTT Activity Solution以50:1的比例混和,並將96孔盤每格加入51μL混和好的XTT試劑,並放入37℃細胞培養相中反應3小時;將反應完成的96孔盤以UV-VIS讀取450nm的吸收光。實驗結果如圖6所示,各條件的不鏽鋼在毒性檢測的顯微鏡定性分析及XTT試劑所換算出來的毒性級數,HDPE與ZDEC為正、負控制組,以培養液培養的控制組Blank定義為100%,健康的細胞在顯微鏡下型態為健康的紡錘狀,並且佈滿在well plate中,而負控制組的ZDEC會造成細胞死亡,細胞型態將會由紡錘狀轉變為圓球狀,並且懸浮在溶液中。由顯微鏡定性 分析以及XTT試劑定量分析可得知,各改質條件在顯微鏡下有良好的細胞型態,並且在XTT試劑的定量下,細胞存活率均大於80%,細胞毒性為0級,說明經過高分子改質後的不鏽鋼均不具有細胞毒性。 The cytotoxicity of the copolymer provided by the present invention is detected according to the standard process stipulated in the regulations ISO 10993-5, and the cells used are mouse fibroblasts (L929) for the experiment, which is divided into 3 days and carried out in total. It is used for qualitative observation by microscope and quantitative detection by XTT reagent. The first day is divided into cell culture and sample toxicity extraction. Cell culture: Take out the L929 cells cultured in the cell culture incubator, wash them twice with PBS; add 1 mL of trypsin (Trypsin-EDTA) to react for 6 minutes to detach the cells on the Flask; use a microscope to observe that the cells have completely detached , add 9 mL of cell culture medium to terminate the trypsin reaction; transfer the desorbed cells to a 15 mL centrifuge tube, and centrifuge at 290 rcf for 5 minutes; remove the supernatant after centrifugation, and refill with 10 mL of cell culture Wash away the cells at the bottom of the centrifuge tube; use a cell counting disc to count the number of cells, and dilute the cells with cell culture medium; the cell concentration of the sample to be observed under a microscope is 150,000 cells/mL, add 1 mL of each to a 12-well multi-well plate Cell dilution solution was added to and cultured in a cell culture incubator for 24 hours; the concentration of cells to be detected by XTT reagent was 100,000 cells/mL, and 0.1 mL was added to a 96-well multi-well plate and cultured in a cell culture incubator for 24 hours. Sample toxicity extraction: The sample was sterilized by UV lamp for 30 minutes, and the L929 cell culture solution was extracted with stainless steel at a ratio of 6cm 2 /mL, and at the same time, HDPE was extracted at a ratio of 0.2g/mL as the cytotoxicity The positive control group was extracted with ZDEC at a ratio of 0.1 g/mL, and as the negative control group of cytotoxicity, the extraction was performed at 37°C and 150 rpm. On the second day, replace the culture medium of the cultured cells on the first day with the extract of the extracted samples, add 1 mL to each 12-well plate, and add 0.1 mL to each 96-well plate, and continue to culture in a cell culture incubator for 24 hours. The third day is divided into qualitative and quantitative, qualitative: the cells in the 12-well plate were washed twice with cell culture medium, and the growth of the cells was observed under a microscope. Quantification: Mix XTT Reagent and XTT Activity Solution at a ratio of 50:1, add 51 μL of the mixed XTT Reagent to each grid of a 96-well plate, and put it in the cell culture phase at 37°C for 3 hours; The plate is read by UV-VIS for absorbance at 450 nm. The experimental results are shown in Figure 6. The qualitative analysis of the toxicity of stainless steel under various conditions and the toxicity grade converted by the XTT reagent, HDPE and ZDEC are the positive and negative control groups, and the control group Blank cultured in culture medium is defined as 100%, healthy cells are in the shape of a healthy spindle under the microscope, and are covered in the well plate, while ZDEC in the negative control group will cause cell death, and the cell shape will change from a spindle shape to a spherical shape, and suspended in solution. From the qualitative analysis of microscope and the quantitative analysis of XTT reagent, it can be known that each modified condition has a good cell shape under the microscope, and under the quantitative analysis of XTT reagent, the cell survival rate is greater than 80%, and the cytotoxicity is 0 grade, indicating that The stainless steel modified by polymer is not cytotoxic.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物的熱穩定性分析Thermal Stability Analysis of Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine Copolymer

本實驗例比較分別含有4VPPS與SBMA的共聚高分子的熱裂解溫度,將PPA30與SBMA70,秤重5mg,使用熱失重分析儀(Thermogravimetric analysis,TGA)來測定材料的熱穩定性質,檢測程序為在120℃維持15分鐘,除去共聚高分子中的水分,除水完成後以10℃/min的升溫速率升溫至800℃,以除水完成的重量作為100%的重量比,當升溫時重量損失10%時的溫度,即為材料的熱裂解溫度。熱裂解溫度由熱失重分析儀所測量,並以10%的重量損失時的溫度定義為共聚高分子的熱裂解溫度,實驗結果如圖8所示,本發明之不含酯類官能基的PPA30的熱裂解溫度在332℃,相較於對照組含酯類官能基的SBMA70的283℃高了約50℃,證明本發明之共聚物結構設計能提升熱穩定性。更重要的是當熱裂解溫度大於300℃時,更有利於各式材料的加工,特別是金屬材料的表面改質。 This experimental example compares the pyrolysis temperature of copolymerized polymers containing 4VPPS and SBMA respectively. Weigh 5 mg of PPA30 and SBMA70, and use a thermogravimetric analysis (TGA) to measure the thermal stability of the material. The detection procedure is as follows: Maintain 120°C for 15 minutes to remove the moisture in the copolymerized polymer. After the water removal is completed, the temperature is raised to 800°C at a rate of 10°C/min. The weight of the water removal is taken as 100% by weight. The temperature at % is the thermal cracking temperature of the material. The thermal cracking temperature is measured by a thermogravimetric analyzer, and the temperature at the time of 10% weight loss is defined as the thermal cracking temperature of the copolymerized polymer. The experimental results are shown in Figure 8. The PPA30 of the present invention does not contain ester functional groups The thermal cracking temperature is 332°C, which is about 50°C higher than the 283°C of the control group SBMA70 containing ester functional groups, which proves that the copolymer structure design of the present invention can improve thermal stability. More importantly, when the pyrolysis temperature is higher than 300°C, it is more conducive to the processing of various materials, especially the surface modification of metal materials.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物的抗生物惰性效能衰變之分析Analysis of Anti-Bioinert Efficacy Decay of Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine Copolymer

本實驗例使用濕熱滅菌程序測試比較本發明之共聚 物具有的抗生物惰性效能衰變的技術效果,具體的方式和結果如下所述。 This experimental example uses a moist heat sterilization procedure to test and compare the copolymerization of the present invention The technical effect of anti-biologically inert performance decay that the substance has, the specific method and result are as follows.

使用以PPA30、SBMA70進行改質的不鏽鋼和SBMA的水凝膠進行溼熱滅菌,並以全血(Human Whole Blood)貼附量來比較含酯類官能基的共聚物與無酯類官能基共聚物之間的熱穩定性質的差異。將改質完的不鏽鋼與水膠對照組浸泡於PBS中,在121℃的溫度下進行20分鐘的濕熱滅菌。將未滅菌的樣品與滅菌後的樣品置於24孔多孔盤中,以PBS在37℃烘箱中膨潤12小時;將膨潤的PBS移除,並以PBS清洗1次;在24孔盤中每格加入1mL的全血,並以37℃,120rpm的搖晃烘箱進行血液的貼附;貼附完的樣品以PBS清洗3次,將樣品移至新的24孔盤,再以PBS清洗3次後,以戊二醛在37℃烘箱中進行1小時的血球細胞的固定,並以SYTO-9染劑對血液進行染色;以PBS清洗1次,使用雷射共軛聚焦掃描式顯微鏡(Confocal Laser Scanning Microscope,CLSM)進行血球細胞的拍攝,並以電腦軟體進行定量的分析。結果如圖9所示,以未改質的不鏽鋼表面定義為100%的貼附量,明顯地,滅菌後的SBMA水膠之血液貼附量比滅菌前的增加1,633%;SBMA70改質的不鏽鋼表面在滅菌後的血液貼附量相對滅菌前的血液貼附量大幅增加947%。表示在濕熱滅菌後其喪失了抗沾黏的效用。但是本發明的PPA30所改質的不鏽鋼表面,結構中不含有酯類官能基,血液貼附量在滅菌前後沒有明顯變 化,表示其結構在滅菌過後仍然保有其抗沾黏的功效。據此證明本發明之共聚物和所構成的膜層具有抗生物惰性效能衰變的技術功效。 Use PPA30, SBMA70 modified stainless steel and SBMA hydrogel for moist heat sterilization, and compare the copolymer with ester functional group and the copolymer without ester functional group by the amount of human whole blood (Human Whole Blood) attachment Differences in thermal stability properties between. Soak the modified stainless steel and water-gel control group in PBS, and perform moist heat sterilization at a temperature of 121°C for 20 minutes. Put the non-sterilized sample and the sterilized sample in a 24-well multi-well plate, and swell with PBS in an oven at 37°C for 12 hours; remove the swelled PBS, and wash once with PBS; each grid in the 24-well plate Add 1mL of whole blood, and attach the blood in a shaking oven at 37°C and 120rpm; wash the adhered samples with PBS for 3 times, move the samples to a new 24-well plate, and wash with PBS for 3 times. Fix the blood cells with glutaraldehyde in an oven at 37°C for 1 hour, and stain the blood with SYTO-9 dye; wash once with PBS, and use a Confocal Laser Scanning Microscope (Confocal Laser Scanning Microscope) , CLSM) to photograph blood cells and perform quantitative analysis with computer software. The results are shown in Figure 9. The unmodified stainless steel surface is defined as 100% of the attached amount. Obviously, the blood attached amount of the sterilized SBMA hydrogel increased by 1,633% compared with that before sterilization; the SBMA70 modified stainless steel The amount of blood attached to the surface after sterilization increased by 947% compared with the amount of blood attached before sterilization. Indicates that it loses its anti-adhesive effect after moist heat sterilization. However, the surface of the stainless steel modified by PPA30 of the present invention does not contain ester functional groups in the structure, and the amount of blood attached does not change significantly before and after sterilization. Chemicalized, indicating that its structure still retains its anti-sticking effect after sterilization. Accordingly, it is proved that the copolymer of the present invention and the formed film layer have the technical effect of resisting biological inert performance decay.

乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物形成之互穿聚合物網絡結構的生物惰性效能之分析Analysis of Bioinert Performance of Interpenetrating Polymer Network Structure Formed by Vinyl Phosphate-4-Vinylpyridine Sulfonate Betaine Copolymer

本發明之乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(PPA70)的磷酸基團和聚乙烯醇(PVA)的氫氧基可藉由反應形成共價鍵結,製成互穿聚合物網絡結構,如式(3)所示,其中X是20~400的整數,Y是30~1500整數。 The phosphoric acid group of the vinylphosphoric acid-4-vinylpyridinesulfonic acid betaine copolymer (PPA70) of the present invention and the hydroxyl group of polyvinyl alcohol (PVA) can form a covalent bond by reacting, making mutual Wear a polymer network structure, as shown in formula (3), wherein X is an integer of 20 to 400, and Y is an integer of 30 to 1500.

式(3)

Figure 110138636-A0101-12-0020-9
Formula (3)
Figure 110138636-A0101-12-0020-9

具有上述共聚物以及該共聚物和PVA製成的互穿聚合物網絡結構膜層的薄膜或基材進行生物惰性效能測試,實驗結果如圖10和圖11所示,本發明之乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物(PPA70)塗布在金屬和陶瓷材料上的膜層對於大腸桿菌的貼附量都小於2%。且經上述如式(2)所示之互穿聚合物網 絡結構改質的聚對苯二甲酸乙二酯、聚丙烯、聚四氟乙烯或聚偏二氟乙烯薄膜的細胞貼附量幾乎是0,都比沒有改質的薄膜低,此表示具有如式(2)所示之互穿聚合物網絡結構改質的塑膠薄膜具有非常好的抗細胞沾黏特性。特別地,具有如式(2)所示之互穿聚合物網絡結構改質的聚四氟乙烯或聚偏二氟乙烯薄膜對於大腸桿菌表現出非常良好的抗沾粘效果,其貼附量也接近於0。據此,具有本發明共聚物製成之互穿聚合物網絡結構的膜層或材料都表現出良好的抗生物分子沾黏效果,是一創新的生物惰性材料。 The film or substrate with the interpenetrating polymer network structure film layer made of the above-mentioned copolymer and the copolymer and PVA is tested for biological inertness, and the experimental results are shown in Figures 10 and 11. Vinyl phosphoric acid of the present invention- The film layer coated with 4-vinylpyridinesulfonate betaine copolymer (PPA70) on metal and ceramic materials is less than 2% for Escherichia coli. And through the above interpenetrating polymer network shown in formula (2) The cell attachment amount of the polyethylene terephthalate, polypropylene, polytetrafluoroethylene or polyvinylidene fluoride film modified by the network structure is almost 0, which is lower than that of the film without modification. The plastic film modified by the interpenetrating polymer network structure represented by formula (2) has very good anti-cell adhesion properties. In particular, the polytetrafluoroethylene or polyvinylidene fluoride film modified with the interpenetrating polymer network structure shown in formula (2) showed a very good anti-adhesion effect on Escherichia coli, and its attachment amount was also close to 0. Accordingly, the film layer or material with the interpenetrating polymer network structure made of the copolymer of the present invention exhibits good anti-biological molecular adhesion effect, and is an innovative biologically inert material.

以上雖以特定範例說明本發明,但並不因此限定本發明之範圍,只要不脫離本發明之要旨,熟悉本技藝者瞭解在不脫離本發明的意圖及範圍下可進行各種變形或變更。此外,摘要部分和標題僅是用來輔助專利文件搜尋之用,並非用來限制本發明之權利範圍。 Although the present invention has been described above with specific examples, the scope of the present invention is not limited thereto. Those skilled in the art understand that various modifications or changes can be made without departing from the intent and scope of the present invention. In addition, the abstract and the title are only used to assist the search of patent documents, and are not used to limit the scope of rights of the present invention.

Figure 110138636-A0101-11-0002-2
Figure 110138636-A0101-11-0002-2

Claims (10)

一種共聚物,該共聚物之結構包含第一鏈段和第二鏈段,該第一鏈段包含複數個磷酸基,該第二鏈段包含複數個吡啶磺酸基甜菜鹼或吡啶羧酸基甜菜鹼,以及上述之第一鏈段和第二鏈段藉由共價鍵連結形成所述之共聚物。 A copolymer, the structure of the copolymer includes a first segment and a second segment, the first segment includes a plurality of phosphoric acid groups, and the second segment includes a plurality of pyridine sulfobetaine or pyridine carboxylic acid groups Betaine, and the above-mentioned first segment and second segment are connected by covalent bonds to form the copolymer. 如請求項1所述之共聚物,該共聚物的化學結構如式(1)所示: As the copolymer described in claim item 1, the chemical structure of the copolymer is as shown in formula (1):
Figure 110138636-A0101-13-0001-10
Figure 110138636-A0101-13-0001-10
其中,R是帶有羧酸根(Carboxylic acid)或磺酸根(sulfonic acid)的官能基k是1~3重複的碳鏈;m是5~500的整數,n是5~500的整數。 Wherein, R is a functional group with carboxylic acid or sulfonic acid; k is a carbon chain repeated from 1 to 3; m is an integer of 5 to 500, and n is an integer of 5 to 500.
如請求項2所述之共聚物,該共聚物是乙烯基磷酸-4-乙烯基吡啶磺酸基甜菜鹼共聚物,和其重量平均分子量是小於120kDa。 The copolymer as claimed in item 2, which is vinylphosphoric acid-4-vinylpyridinesulfonate betaine copolymer, and its weight average molecular weight is less than 120kDa. 如請求項3所述之共聚物,該乙烯基磷酸-4-乙烯基 吡啶磺酸基甜菜鹼共聚物是由乙烯基磷酸和4-乙烯基吡啶磺酸基甜菜鹼進行自由基聚合反應所製成,該乙烯基磷酸和4-乙烯基吡啶磺酸基甜菜鹼的反應莫耳比例範圍是約9:1到1:9。 The copolymer as described in claim 3, the vinyl phosphate-4-vinyl Pyridine sulfobetaine copolymer is prepared by free radical polymerization of vinyl phosphoric acid and 4-vinylpyridine sulfobetaine, the reaction of vinyl phosphoric acid and 4-vinylpyridine sulfobetaine The molar ratio ranges from about 9:1 to 1:9. 一種生物惰性材料,包含一膜層和一基材,該膜層是由包含如請求項1~4所述之共聚物的組成所構成,並以配位共價鍵結或化學接枝錨定在該基材的表面,藉此形成所述的生物惰性材料。 A biologically inert material, comprising a film layer and a substrate, the film layer is composed of a copolymer as described in Claims 1 to 4, and is anchored by coordination covalent bonding or chemical grafting On the surface of the substrate, thereby forming said bioinert material. 如請求項5所述生物惰性之材料,該膜層的水接觸角是約小於60度。 For the biologically inert material as claimed in item 5, the water contact angle of the film layer is about less than 60 degrees. 如請求項5所述之生物惰性材料,該膜層還包含一如式(2)所示的聚乙烯醇和乙烯基磷酸所形成的互穿聚合物網絡結構: As the biological inert material described in claim item 5, the film layer also includes an interpenetrating polymer network structure formed by polyvinyl alcohol and vinyl phosphoric acid as shown in formula (2):
Figure 110138636-A0101-13-0002-11
Figure 110138636-A0101-13-0002-11
其中X是5~500的整數,Y是5~7000的整數。 Where X is an integer from 5 to 500, and Y is an integer from 5 to 7000.
如請求項5所述之生物惰性材料,該基材包含不鏽鋼、鈦合金、玻璃、矽晶圓、陶瓷、聚對苯二甲酸乙二酯、聚丙烯、聚二甲基矽氧烷、聚四氟乙烯或聚偏二氟乙烯。 The biologically inert material as described in Claim 5, the base material includes stainless steel, titanium alloy, glass, silicon wafer, ceramics, polyethylene terephthalate, polypropylene, polydimethylsiloxane, polytetrafluoroethylene Vinyl fluoride or polyvinylidene fluoride. 如請求項5所述之生物惰性材料,係應用於製備心導管、血管支架、內視鏡或手術器械。 The biologically inert material as described in Claim 5 is applied to the preparation of cardiac catheters, vascular stents, endoscopes or surgical instruments. 一種防止金屬表面沾黏生物分子的方法,其步驟包含使請求項1~4所述的共聚物配位共價鍵結在該金屬表面或以化學接枝形成互穿聚合物網絡結構,藉此防止該金屬表面沾黏生物分子,該配位共價鍵結係由磷酸基和該金屬表面所含的鉻所形成。 A method for preventing metal surfaces from adhering to biomolecules, the steps of which include covalently bonding the copolymer described in claims 1 to 4 on the metal surface or forming an interpenetrating polymer network structure by chemical grafting, whereby To prevent the metal surface from adhering to biomolecules, the coordination covalent bond is formed by the phosphoric acid group and the chromium contained in the metal surface.
TW110138636A 2021-10-15 2021-10-15 A bio-inert material and its application for preventing biofouling from metal surface TWI800039B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW110138636A TWI800039B (en) 2021-10-15 2021-10-15 A bio-inert material and its application for preventing biofouling from metal surface

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW110138636A TWI800039B (en) 2021-10-15 2021-10-15 A bio-inert material and its application for preventing biofouling from metal surface

Publications (2)

Publication Number Publication Date
TWI800039B TWI800039B (en) 2023-04-21
TW202317652A true TW202317652A (en) 2023-05-01

Family

ID=86948781

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110138636A TWI800039B (en) 2021-10-15 2021-10-15 A bio-inert material and its application for preventing biofouling from metal surface

Country Status (1)

Country Link
TW (1) TWI800039B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112292404A (en) * 2018-06-04 2021-01-29 罗地亚经营管理公司 Methods, compositions, and copolymers useful therefor for reducing or preventing colloidal adhesion and/or fouling on substrates

Also Published As

Publication number Publication date
TWI800039B (en) 2023-04-21

Similar Documents

Publication Publication Date Title
JP6400666B2 (en) Cross-linked zwitterionic hydrogel
Balakrishnan et al. Chemical modification of poly (vinyl chloride) resin using poly (ethylene glycol) to improve blood compatibility
JP6085075B2 (en) Ultra-low fouling sulfobetaine and carboxybetaine materials and related methods
CA2745440C (en) Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
Kwon et al. Zwitterionic sulfobetaine polymer-immobilized surface by simple tyrosinase-mediated grafting for enhanced antifouling property
JPH1199362A (en) Bioactive coating method on base material surface and product composed of base material coated by the same way
Kuo et al. Improvement of hemocompatibility on materials by photoimmobilization of poly (ethylene glycol)
JPWO2008023604A1 (en) Surface modifying compound and surface modification method using the same
WO2014076682A1 (en) Method for grafting polymers on metallic substrates
Liu et al. Rational design of a zwitterionic–phosphonic copolymer for the surface antifouling modification of multiple biomedical metals
Lin et al. Hemocompatibility and cytocompatibility of styrenesulfonate-grafted PDMS–polyurethane–HEMA hydrogel
Wang et al. Design of hemocompatible and antifouling PET sheets with synergistic zwitterionic surfaces
KR20210142664A (en) Zwitterionic Copolymer Coatings and Related Methods
Chang Designs of zwitterionic polymers
Choi et al. Surface immobilization of biocompatible phospholipid polymer multilayered hydrogel on titanium alloy
Asanuma et al. Hybridization of poly (2-methacryloyloxyethyl phosphorylcholine-block-2-ethylhexyl methacrylate) with segmented polyurethane for reducing thrombogenicity
Xu et al. Polyurethane/Dermatan Sulfate Copolymers as Hemocompatible, Non‐Biofouling Materials
JP7158993B2 (en) Phosphorylcholine group-containing copolymer and biomedical substrate
Chen et al. Studies on segmented polyetherurethane for biomedical application: Effects of composition and hard‐segment content on biocompatibility
JP5656241B2 (en) Method for modifying surface biocompatibility
TW202317652A (en) A bio-inert material and its application for preventing biofouling from metal surface
Xu et al. Phospholipid based polymer as drug release coating for cardiovascular device
JP3580022B2 (en) Block copolymers and medical materials
JP2018123275A (en) Cell adhesion inhibitor
JP2004298223A (en) Biocompatible material